|
|
Volumn 42, Issue 2, 2011, Pages
|
|
Response to letter by Hadjiev et al
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
CALCIUM CHANNEL BLOCKING AGENT;
EZETIMIBE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN;
ROSUVASTATIN;
UBIDECARENONE;
BRAIN HEMORRHAGE;
CAROTID ATHEROSCLEROSIS;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG POTENCY;
HUMAN;
LETTER;
MYALGIA;
MYOPATHY;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
STROKE;
|
|
EID: 79251622788
PISSN: 00392499
EISSN: None
Source Type: Journal
DOI: 10.1161/STROKEAHA.110.595132 Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|
